The evidence from family, twin, and adoption studies has established that the risk for developing schizophrenia involves a substantial genetic component (McGuffin, Farmer, and Gottesman, 1987). The major challenge now confronting researchers is to determine the mode or modes of genetic transmission. Advances in the last decade in recombinant DNA technology, especially improvements in methods for generating and isolating restriction fragment length polymorphisms (RFLPs), have made it possible to use DNA sequence polymorphisms to trace alleles at specific genomic loci. The power of these methods have recently been demonstrated by two landmark studies (Barrett et al., 1988; Sherrington et al., 1988) providing the first evidence for genetic linkage in schizophrenia. These findings foreshadow a series of breakthroughs in clarifying the etiology and pathophysiology of schizophrenia. The major objective of this proposed Diagnostic Center is to work as one of three centers in developing a sample of 200 multiplex schizophrenic families for subsequent linkage studies. To this end, approximately 67 families will be recruited from a Harvard Medical School consortium of hospitals from the 6-month to the 4 1/2 year period of a 5-year contract. Families will be sought with two or more affected siblings and an average of seven first-degree relatives, including both parents. More two- generation families. Selected probands and relatives will receive extensive assessment using state of the art tools in psychiatric epidemiology and neuropsychology. Blood samples will also be obtained from all subjects for transformation into lymphoblast cell lines for subsequent linkage analyses. The principal hypothesis of this study is that a major gene or genes contributes to the etiology of this disorder, which can be identified through genetic linkage analysis of a well-defined sample of multiplex families. The key question is whether there are specific DNA markers which co-segregate with the disease trait. Linkage analyses of our center sample will focus first on the chromosome 5 region where linkage has been shown as well on DNA markers linked to loci implicated in catecholamine metabolism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01MH046318-05
Application #
3553938
Study Section
Special Emphasis Panel (SRCM (10))
Project Start
1989-09-30
Project End
1994-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
(2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50:668-681
Sanders, A R; Drigalenko, E I; Duan, J et al. (2017) Transcriptome sequencing study implicates immune-related genes differentially expressed in schizophrenia: new data and a meta-analysis. Transl Psychiatry 7:e1093
Liu, C; Bousman, C A; Pantelis, C et al. (2017) Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations. Transl Psychiatry 7:e1037
Zuo, Lingjun; Tan, Yunlong; Li, Chiang-Shan R et al. (2016) Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence. Am J Med Genet B Neuropsychiatr Genet 171:1057-1071
Lee, Minyoung; Aggen, Steven H; Otowa, Takeshi et al. (2016) Assessment and characterization of phenotypic heterogeneity of anxiety disorders across five large cohorts. Int J Methods Psychiatr Res 25:255-266
Johnson, Eric O; Hancock, Dana B; Levy, Joshua L et al. (2016) KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. Addict Biol 21:1217-1232
Rees, Elliott; Kendall, Kimberley; Pardiñas, Antonio F et al. (2016) Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia. JAMA Psychiatry 73:963-969
Han, Jun; Walters, James T R; Kirov, George et al. (2016) Gender differences in CNV burden do not confound schizophrenia CNV associations. Sci Rep 6:25986
Otowa, T; Hek, K; Lee, M et al. (2016) Meta-analysis of genome-wide association studies of anxiety disorders. Mol Psychiatry 21:1391-9
van den Berg, Stéphanie M; de Moor, Marleen H M; Verweij, Karin J H et al. (2016) Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium. Behav Genet 46:170-82

Showing the most recent 10 out of 116 publications